Companies / AYA

ARTRYA LIMITED

ASX:AYAHealth Care Equipment & Services
163.0M shares on issueASX (delayed) · as of 28 July 2026$5.62price · delayed$919.1Mmarket cap · indicative
D
Dilution grade

Share count grew 107% in 24 months; 3 cash raises in 24 months; runway 4–8 quarters

Cash runway6.1 quarters of funding
Share-count growth (24m)107.1%
Raise cadence (24m)3 cash raises
Options & rights overhang12.0% of shares
In-the-money supply10.9% of shares
Pending proposed issuesnone

ARTRYA LIMITED's ordinary share count grew 107.1% between April 2024 and June 2026, to 163M shares. The company raised capital three times in that 24-month window for total disclosed proceeds of A$100.0M, most recently a A$80.0M placement in September 2025. Options and rights on issue could convert into 20M new shares, equal to 12.0% of the current share count, of which 11% are in the money at the current share price; the nearest expiry is November 2026. At the March 2026 quarter ARTRYA reported A$38.3M in available cash, about 6.1 quarters of funding at its recent spending rate. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
12.0%
Max option dilution
10.9%
ITM option dilution
1
Raises · last 12 months
6.1 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 163.0M per ASX (delayed) (28 July 2026).
105.8M126.8M147.8MDec 24Sept 25July 26Cash raise · 4 Sept 2025Cash raise · 11 Feb 2025

Cash runway

6.1 qtrs
More than four quarters of funding at the recent spend rate.
$38.3M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
15 July 20263H · cancellationAYA : ORDINARY FULLY PAID163.0MAppendix 3H
10 July 20263H · cancellationAYA : ORDINARY FULLY PAID163.0MAppendix 3H
7 July 20263G · unquotedORDINARY FULLY PAID163.0MAppendix 3G
25 June 20262A · quoted issueAYA : ORDINARY FULLY PAID163.0MAppendix 2A
18 June 20262A · quoted issueAYA : ORDINARY FULLY PAID162.9MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

3 cash raises in the last 24 months · 1 in the last 12 months

$80.0M
Placement
4 Sept 2025 COMPLETE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

12.0%
Total overhang · of current shares
10.9%
In the money · at current price
19.5M
Potential new shares
Nov 2026
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
10 July 2026Bernie RidgewaySell—750k—3Y notice
18 June 2026Bernie RidgewayOther750k750k$750k3Y notice
11 June 2026Bernie RidgewaySell——$1.4M3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

22 July 2026$PNortheast Georgia Health System goes live with Salix
15 July 2026Notification of cessation of securities - AYA
10 July 2026Change of Director's Interest Notice - B Ridgeway
10 July 2026Notification of cessation of securities - AYA
7 July 2026Notification regarding unquoted securities - AYA
30 June 2026Becoming a substantial holder
25 June 2026Application for quotation of securities - AYA
25 June 2026Share Issue and Cleansing Notice
18 June 2026Change of Director's Interest Notice - B Ridgeway
18 June 2026Application for quotation of securities - AYA
18 June 2026Issue of Shares and Cleansing Notice
11 June 2026Change of Director Interests Notice
11 June 2026Sale of Shares to Fund Options Exercise
2 June 2026Application for quotation of securities - AYA
2 June 2026Issue of Shares and Cleansing Notice
19 May 2026Ceasing to be a substantial holder
17 May 2026Artrya appoints Clayton Hatch as Chief Financial Officer
29 Apr 2026$PMarch Quarterly Activities Report and Appendix 4C
14 Apr 2026Change of Director's Interest Notice - B Ridgeway
14 Apr 2026Application for quotation of securities - AYA

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.